These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8895767)

  • 1. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
    Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
    Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.
    Nagane M; Levitzki A; Gazit A; Cavenee WK; Huang HJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5724-9. PubMed ID: 9576951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
    Jungbluth AA; Stockert E; Huang HJ; Collins VP; Coplan K; Iversen K; Kolb D; Johns TJ; Scott AM; Gullick WJ; Ritter G; Cohen L; Scanlan MJ; Cavenee WK; Old LJ
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):639-44. PubMed ID: 12515857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo.
    Sawa H; Murakami H; Kumagai M; Nakasato M; Yamauchi S; Matsuyama N; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
    Acta Neuropathol; 2004 Jun; 107(6):523-31. PubMed ID: 15024582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
    Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
    Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells.
    Wang ZH; Ding MX; Yuan JP; Jin ML; Hao CF; Chew-Cheng SB; Ng HK; Chew EC
    Anticancer Res; 1999; 19(5B):4167-70. PubMed ID: 10628370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
    Staverosky JA; Muldoon LL; Guo S; Evans AJ; Neuwelt EA; Clinton GM
    Clin Cancer Res; 2005 Jan; 11(1):335-40. PubMed ID: 15671564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae.
    Abulrob A; Giuseppin S; Andrade MF; McDermid A; Moreno M; Stanimirovic D
    Oncogene; 2004 Sep; 23(41):6967-79. PubMed ID: 15273741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
    Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
    Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.